DR ANTHONY MELVIN CRASTO,WorldDrugTracker, helping millions, A 90 % paralysed man in action for you, I am suffering from transverse mylitis and bound to a wheel chair, With death on the horizon, nothing will not stop me except God................DR ANTHONY MELVIN CRASTO Ph.D ( ICT, Mumbai) , INDIA 25Yrs Exp. in the feld of Organic Chemistry,Working for GLENMARK GENERICS at Navi Mumbai, INDIA. Serving chemists around the world. Helping them with websites on Chemistry.Million hits on google, world acclamation from industry, academia, drug authorities for websites, blogs and educational contribution

Saturday 20 December 2014

Clobenzorex Hydrochloride


Clobenzorex structure.svg

Molecular Formula: C16H18ClN*HCl
Molecular Weight: 259.774 + 36.461
InChI=1/C16H18ClN/c1-13(11-14-7-3-2-4-8-14)18-12-15-9-5-6-10-16(15)17/h2-
10,13,18H,11-12H2,1H3
IUPAC Name: (+)-N-(o-Chlorobenzyl)--methylphenethylamine hydrochloride
CAS Number: 18966-32-0
PubChem: 71675
Spectrometer: Varian Mercury 400 MHz
Solvent: CD3OD
Sample Concentration: 13.83 mg


Original 1D Proton Spectrum:

Original 1D Proton Spectrum


1D Proton Spectrum (6.31 ppm Maleic Acid, 4.89 ppm H2O, TMS Subtracted):

1D Proton Spectrum


1D Carbon Spectrum (168.4 ppm Maleic Acid, Deuterated Solvent, TMS Subtracted):

1D Carbon Spectrum


Automated VerifyIt Proton Assignments:

Proton Assignments

Automated VerifyIt Carbon Assignments:

Carbon Assignments

Top 10 FindIt Molecular Structures Consistent With Molecular Formula and Proton Resonances:

The correct structure is at position 2.
FindIt Structures

 Best 10 structures in decreasing rating (structure ID shown in parentheses):
    1: 0.973205 (  203629)    2: 0.971108 (   71675)    3: 0.970448 (  202811)
    4: 0.966469 (  408921)    5: 0.966159 (  409716)    6: 0.959686 ( 3399675)
    7: 0.956398 (  408206)    8: 0.953191 ( 3862089)    9: 0.951410 (  411609)
   10: 0.945905 (  851538)
   

Top 10 FindIt Molecular Structures Consistent With Proton and Carbon Resonances:

The correct structure is at position 1.
FindIt Structures

 Best 10 structures in decreasing rating (structure ID shown in parentheses):
    1: 0.933222 (   71675)    2: 0.932409 (  211179)    3: 0.932318 (  203629)
    4: 0.930154 (  202811)    5: 0.927720 ( 9306444)    6: 0.927015 (  201367)
    7: 0.926608 (  714984)    8: 0.926380 ( 6918952)    9: 0.926371 ( 7316106)
   10: 0.926113 ( 3043270)
   

2D Multiplicity-Edited HSQC Spectrum:

2D Multiplicity-Edited HSQC Spectrum

Determined HSQC Correlations:

Determined HSQC Correlations

Top 10 FindIt Molecular Structures Consistent With Molecular Formula, Proton Resonances, and Protonated Carbon (HSQC) Resonances:

The correct structure is at position 2.
FindIt Structures

 Best 10 structures in decreasing rating (structure ID shown in parentheses):
    1: 0.931783 (  203629)    2: 0.929581 (   71675)    3: 0.929339 (  202811)
    4: 0.905630 (  408921)    5: 0.901098 (  409716)    6: 0.896999 ( 3399675)
    7: 0.867804 (  851538)    8: 0.867529 ( 8898284)    9: 0.849200 ( 3862089)
   10: 0.821569 ( 2826788)
   

2D DQF-COSY Spectrum:

2D DQF-COSY Spectrum

AssembleIt HSQC & DQF-COSY Derived Carbon-Carbon Correlations:

AssembleIt HSQC & DQF-COSY Derived Correlations

2D HMBC Spectrum:

2D HMBC Spectrum

AssembleIt HSQC, HMBC & DQF-COSY Derived Correlations:

AssembleIt Derived Correlations

Comments:

Clobenzorex is an appetite suppressant for the treatment of obesity.

For a full structure elucidation, an 15N-HMBC spectrum would be highly desirable. A DQF-COSY spectrum should resolve vicinal proton-proton couplings down to 3 Hz. But FindIt identifies this molecule based on the carbon and proton resonances alone.











 
 amcrasto@gmail.com



http://newdrugapprovals.org/

DRUG APPROVALS BY DR ANTHONY MELVIN CRASTO

 DRUG APPROVALS BY DR ANTHONY MELVIN CRASTO .....FOR BLOG HOME CLICK HERE

Join me on Linkedin

View Anthony Melvin Crasto Ph.D's profile on LinkedIn

Join me on Facebook FACEBOOK
Join me on twitterFollow amcrasto on Twitter     
Join me on google plus Googleplus

 amcrasto@gmail.com






No comments:

Post a Comment